Safety and effectiveness of eribulin in Japanese patients with soft tissue sarcoma including rare subtypes: a post-marketing observational study
2022 · BMC Cancer · 10 citations
https://doi.org/10.1186/s12885-022-09527-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
3.4K
Citations
18
h-index
26
i10-index
Hiroyuki Narahara is an academic researcher from Hyogo Prefectural Nishinomiya Hospital. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Esophageal Cancer Research and Treatment & Helicobacter pylori-related gastroenterology studies. The author has an h-index of 18, co-authored 69 publications.
Click to start Chat